These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 27424873

  • 1. Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: A case report.
    Casas Reza P, Gestal Vázquez M, Outeiro Rosato Á, López Álvarez S, Diéguez García P.
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):105-107. PubMed ID: 27424873
    [Abstract] [Full Text] [Related]

  • 2. [Anesthetic management for electroconvulsive therapy using rocuronium bromide and sugammadex sodium in a patient with suspected malignant syndrome].
    Maeda T, Enomoto T, Kamiyama Y, Inada E.
    Masui; 2011 Dec; 60(12):1384-6. PubMed ID: 22256579
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The use of rocuronium and sugammadex in a patient with a history of suxamethonium allergy.
    Messer B, Wilkes J.
    Anaesthesia; 2011 Sep; 66(9):844. PubMed ID: 21831084
    [No Abstract] [Full Text] [Related]

  • 5. Electroconvulsive therapy using rocuronium and sugammadex in patient with neuroleptic malignant syndrome.
    Saeki N, Kwon R, Migita T, Fukuda H, Hamada H, Kawamoto M.
    Anaesth Intensive Care; 2011 Jul; 39(4):762-3. PubMed ID: 21823397
    [No Abstract] [Full Text] [Related]

  • 6. With the advent of sugammadex, a succinylcholine-free anaesthetic in electroconvulsive therapy may be the future standard.
    Chow TK.
    Anaesth Intensive Care; 2011 Nov; 39(6):1154-5. PubMed ID: 22165380
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.
    Trollor JN, Sachdev PS.
    Aust N Z J Psychiatry; 1999 Oct; 33(5):650-9. PubMed ID: 10544988
    [Abstract] [Full Text] [Related]

  • 16. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K, Ishiguro T.
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [Abstract] [Full Text] [Related]

  • 17. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PA, Smeets JM, Foubert L.
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome associated with clozapine use.
    Anderson ES, Powers PS.
    J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
    [Abstract] [Full Text] [Related]

  • 20. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A, Borkar HA, Chandak S.
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.